Anzeige
Mehr »
Login
Montag, 26.10.2020 Börsentäglich über 12.000 News von 649 internationalen Medien
Taat Lifestyle hat mit der Produktion der 1. Charge von Beyond Tobacco™ begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0H1J1 ISIN: US69329Y1047 Ticker-Symbol: PDL 
Tradegate
26.10.20
13:55 Uhr
1,912 Euro
+0,011
+0,58 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
PDL BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
PDL BIOPHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,8811,92222:32
1,8711,93221:34

Aktuelle News zur PDL BIOPHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.10.PDL BIOPHARMA, INC. - 8-K, Current Report9
PDL BIOPHARMA Aktie jetzt für 0€ handeln
02.10.PDL BioPharma -16% PM on completion of LENSAR spin off29
02.10.PDL BIOPHARMA, INC. - 8-K, Current Report9
01.10.XFRA CAPITAL ADJUSTMENT INFORMATION - US69329Y104782CAPITAL ADJUSTMENT INFORMATION - 02.10.2020;Das Instrument PDL US69329Y1047 PDL BIOPHARMA INC. DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 01.10.2020 und ex Kapitalmassnahme am 02.10.2020 The...
► Artikel lesen
10.09.PDL BioPharma Board Approves Spin-Off Of LENSAR; To Complete Spin-Off On October 1, 2020287WASHINGTON (dpa-AFX) - PDL BioPharma Inc. (PDLI) said its Board has approved the separation of LENSAR Inc., a majority owned subsidiary of PDL, from PDL in the form of a dividend involving...
► Artikel lesen
09.09.PDL BioPharma Closes Divestiture Of Noden Pharmaceutical Business249WASHINGTON (dpa-AFX) - PDL BioPharma, Inc. (PDLI) announced the closing of the sale of its subsidiaries Noden Pharma DAC and Noden Pharma USA to Stanley Capital. This will result in payments...
► Artikel lesen
09.09.PDL BIOPHARMA, INC. - 8-K, Current Report-
31.08.PDL BIOPHARMA, INC. - 8-K, Current Report1
28.08.PDL BioPharma to buy ~$15M convertible notes in tender offer7
26.08.PDL BioPharma advancing Lensar spinoff12
26.08.PDL BIOPHARMA, INC. - 8-K, Current Report2
25.08.PDL BioPharma - Selling off Noden772PDL BioPharma recently announced an agreement to divest its Noden subsidiary to Stanley Capital for up to $48.25m in cash. $12m is due at deal closure (currently expected in mid-August), with an additional...
► Artikel lesen
20.08.PDL BIOPHARMA, INC. - 8-K, Current Report1
12.08.PDL BioPharma inks settlement agreement with Wellstat8
12.08.PDL BioPharma Reaches Settlement With Wellstat Parties272WASHINGTON (dpa-AFX) - PDL BioPharma, Inc. (PDLI) has entered into a settlement agreement with related entities of Defined Diagnostics, LLC, or Wellstat Parties, resolving litigation relating...
► Artikel lesen
12.08.PDL BIOPHARMA, INC. - 8-K, Current Report5
07.08.PDL BioPharma, Inc. (PDLI) CEO Dominique Monnet on Q2 2020 Results - Earnings Call Transcript10
06.08.PDL BioPharma, Inc. 2020 Q2 - Results - Earnings Call Presentation4
06.08.EARNINGS SUMMARY: Details of PDL BioPharma Inc. Q2 Earnings Report243WASHINGTON (dpa-AFX) - Below are the earnings highlights for PDL BioPharma Inc. (PDLI):-Earnings: -$49.97 million in Q2 vs. -$4.42 million in the same period last year. -EPS: -$0.43 in...
► Artikel lesen
30.07.PDL BioPharma Sells Noden Pharma for $48.3M4
Seite:  Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,6,11